24 March 2022>: Clinical Research
Efficacy of PD-1 Inhibitor Combined with Bevacizumab in Treatment of Advanced Endometrial Cancer Patients with Mismatch Repair Deficiency (dMMR)/High-Level Microsatellite Instability (MSI-H)
Ying Liao 1BCE , Changhua Zhu 2A* , Xiaoxia Song 1CF , Jiugen Ruan 2BCDF , Yao Ding 2CF , Yuan Chen 3BCDEF , Qiujuan Yang 1FDOI: 10.12659/MSM.934493
Med Sci Monit 2022; 28:e934493
Figure 2 Tissue samples were tested by capillary electrophoresis to confirmation MSI. The figure was edited using Microsoft PowerPoint 2010 (Microsoft, Redmond, WA, USA) from a screen shot from the Applied Biosystems (ABI 3500 DX) in Shanghai Tech Laboratory Co., Ltd. (Shanghai, China).